Increased expression of CXCL16, a bacterial scavenger receptor, in the colon of children with ulcerative colitis.

[1]  S. Geller,et al.  Crohn disease , 2015, Autopsy & case reports.

[2]  R. Puri,et al.  IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis , 2014, Gut.

[3]  Dan Knights,et al.  Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome , 2013, Gut.

[4]  S. Melgar,et al.  Pattern recognition receptors--molecular orchestrators of inflammation in inflammatory bowel disease. , 2013, Cytokine & growth factor reviews.

[5]  W. Sandborn,et al.  Crohn's disease , 2012, The Lancet.

[6]  S. Cox,et al.  Microbiota Separation and C-reactive Protein Elevation in Treatment-naïve Pediatric Granulomatous Crohn Disease , 2012, Journal of pediatric gastroenterology and nutrition.

[7]  R. Satokari,et al.  Expression of Microbiota, Toll-like Receptors, and Their Regulators in the Small Intestinal Mucosa in Celiac Disease , 2012, Journal of pediatric gastroenterology and nutrition.

[8]  R. Siebert,et al.  Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function , 2012, Science.

[9]  宇座 徳光.  SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation , 2011 .

[10]  S. Brand,et al.  Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation , 2010, Inflammatory bowel diseases.

[11]  B. Müller-Myhsok,et al.  Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease. , 2008, Clinical immunology.

[12]  F. Seibold,et al.  CXCL16 is a surrogate marker of inflammatory bowel disease , 2008, Scandinavian journal of gastroenterology.

[13]  R. Baldassano,et al.  Lamina Propria and Circulating Interleukin-8 in Newly and Previously Diagnosed Pediatric Inflammatory Bowel Disease Patients , 2007, Digestive Diseases and Sciences.

[14]  R. Macdermott.  Chemokines in the Inflammatory Bowel Diseases , 1999, Journal of Clinical Immunology.

[15]  T. Kita,et al.  Cutting Edge: SR-PSOX/CXC Chemokine Ligand 16 Mediates Bacterial Phagocytosis by APCs Through its Chemokine Domain1 , 2003, The Journal of Immunology.

[16]  G. Rogler,et al.  Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6 , 2000, Gut.

[17]  R. Macdermott,et al.  Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. , 1999 .

[18]  R. Macdermott,et al.  Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon , 1999, American Journal of Gastroenterology.

[19]  L. Mazzucchelli,et al.  Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. , 1994, The American journal of pathology.

[20]  W. Tremaine,et al.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.

[21]  G PLACITELLI,et al.  [Ulcerative colitis]. , 1958, La Riforma medica.

[22]  C. FordAlexander,et al.  ULCERATIVE colitis. , 1997, Journal of the American Medical Association.